Prof. Dr. Hansjürgen Volkmer
Head of Pharma & Biotech
Prof. Dr. Hansjürgen Volkmer
Head of Pharma & Biotech
phone
+49 7121 51530-44
email
Contact via email
- 1998 - today
- Head of Pharma & Biotech
- 1994 - 1998
- Postdoc at the Max Delbrück Center for Molecular Medicine in Berlin-Buch, Germany
- 1989 - 1994
- Postdoc at the Center for Molecular Neurobiology in Hamburg, Germany
- 1989 - 1989
- Doctorate in genetics at the University of Tübingen
- 1979 - 1984
- Study of biology at the University of Tübingen
After completing his PhD at the University of Tübingen in 1989, he joined the NMI in 1998 as a division head of the Pharma & Biotech group. His research interests include - Molecular Neuroscience, inhibitory synapse plasticity and iPSC-based disease models.
Selected publications
- Breitmeyer R, Vogel S, Heider J, Hartmann SM, Wüst R, Keller AL, Binner A, Fitzgerald JC, Fallgatter AJ, Volkmer H. (2023) Regulation of synaptic connectivity in schizophrenia spectrum by mutual neuron-microglia interaction. Commun Biol. 2023 Apr 29;6(1):472. doi: 10.1038/s42003-023-04852-9
- Fanny Joly, Pauline Jeckel Martin Kriebel, Sanket Raut, Nicole El Massioui, Cyrille Vaillend, Luke R. Johnson, Hansjürgen Volkmer & Valérie Doyère (2022). Disruption of amygdala Tsc2 in adolescence leads to changed prelimbic cellular activity and generalized fear responses at adulthood in rats. Cereb Cortex. 32(20):4619-4639. doi: 10.1093/cercor/bhab506
- Grunwald L-M, Stock R, Haag K, Buckenmaier S, Eberle M-C, Wildgruber D, Storchak H, Kriebel M, Weißgraeber S, Mathew L, Singh Y, Loos M, Ka Wan Li , Kraushaar U, Fallgatter AJ, Volkmer H. 2019. Comparative characterization of human induced pluripotent stem cells (hiPSC) derived from patients with schizophrenia and autism. Translational Psychiatry 9(1):179. doi: 10.1038/s41398-019-0517-3
- Saha R., Knapp S., Chakraborty D., Horovitz O., Albrecht A., Kriebel M. , Kaphzan H., Ehrlich I., Volkmer H. , Gal Richter-Levin (2017). GABAergic synapses at the axon initial segment of basolateral amygdala projection neurons modulate fear extinction. Neuropsychopharmacology. 42(2):473-484. doi: 10.1038/npp.2016.205
- Wuchter J, Beuter S, Treindl F, Herrmann T, Zeck G, Templin MF, and H. Volkmer. 2012. A comprehensive small interfering RNA screen identifies signaling pathways required for gephyrin clustering. J Neurosci. 32(42):14821-34. doi: 10.1523/JNEUROSCI.1261-12.2012
NMI Natural and Medical Sciences Institute
at the University of Tübingen
Markwiesenstraße 55, 72770 Reutlingen
Tel.: +49 7121 51530-0
Mail: info@nmi.de
Follow us now
